4bases announces its new partnership with Saphetor SA
4bases announces its new partnership with Saphetor SA to accelerate data interpretation for targeted NGS panels.
Manno, December 3st, 2019.
4bases SA, a Swiss-based company specialized in the development, production, and commercialization of reagent kits and gene assays for clinical NGS, announced today a partnership with Saphetor SA, a Swiss precision medicine company and the creator of VarSome, a suite of bioinformatics solutions,
Saphetor’s VarSome Clinical is a clinically-certified CE-IVD and HIPAA-compliant platform empowering fast and accurate variant discovery, annotation, and interpretation of NGS data, which is now available to Italian customers either as the Stand-alone Solution or as the Bundled Solution.
4bases’s NGS-based panels are now bundled with VarSome Clinical for data analysis, interpretation, and reporting. The validated Bundled Solution enables biologists, geneticists, and medical doctors to process and interpret 4bases sequencing data more rapidly and precisely, using VarSome Clinical’s intuitive and feature-rich interface.
At the same time, 4bases has become a distributor for the Stand-alone Solution of VarSome Clinical in Italy, allowing Italian clinicians and researchers to implement VarSome Clinical as a tool for data analysis of any NGS sample, be it a gene panel, exome or whole genome.
Fabio Grandi, COO of 4bases, said: ‘The partnership with Saphetor is a very important step in 4bases’ development and excellent news for the many healthcare professionals who need more accurate and faster data interpretation for targeted NGS panels. We’re delighted with today’s announcement’.
Andreas Massouras, CEO and Founder of Saphetor SA, commented: ‘We are very pleased to partner with 4bases and combine our offerings for the benefit of 4bases’s rapidly growing number of customers, and we welcome 4bases as a distributor for Italy.’
4bases is a Swiss-based company specialized in the development, production, and commercialization of reagent kits for NGS clinically validated for diagnostic purposes. It was launched in 2013 to address increasing medical needs in the fields of prevention and precision medicine. 4bases is ISO13485:2016 certified and operates according to the European directive on in vitro diagnostic medical devices (CE – IVD). Its portfolio addresses genetic diagnostic needs in several kinds of cancers and genetic diseases. 4bases’ vision is that as both precision and preventive medicine will develop significantly in the next years the need for clinically validated diagnostic genetic tests for somatic and germinal analyses will strongly increase. 4bases is therefore continuously developing new solutions both as companion diagnostics and for inherited gene mutations. 4bases plan is to accelerate its development program through commercial and technological partnership.
About Saphetor SA
Saphetor SA, is a Swiss precision-medicine company dedicated to large-scale identification and interpretation of human genetic variants by leveraging proprietary algorithms and expert domain knowledge. Saphetor is the creator of VarSome, a suite of intuitive and data-driven bioinformatics solutions both for clinicians and researchers. VarSome.com professional community and search engine is freely accessible, featuring a widely-recognized community-driven knowledge base that enables flexible queries across more than 35 genetic and genomic data resources. VarSome Clinical is a clinically-certified CE-IVD and HIPAA compliant platform allowing fast and accurate variant discovery, annotation, and interpretation of NGS data for whole genomes, exomes, and gene panels. VarSome Clinical helps molecular geneticists and clinicians reach faster and more accurate diagnoses and treatment decisions for genetic conditions.